VRTX

Vertex Pharmaceuticals Incorporated News Headlines

$112.47
*  
1.62
1.46%
Get VRTX Alerts
*Delayed - data as of Oct. 31, 2014 15:55 ET  -  Find a broker to begin trading VRTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VRTX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Why You Shouldn't Worry About Gilead Sciences, Inc.
10/30/2014 8:10:02 AM - Motley Fool


Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog
10/29/2014 1:00:00 PM - Zacks.com


Nasdaq 100 Movers: FB, WDC
10/29/2014 12:36:07 PM - BNK Invest


Vertex Pharma Q3 Loss Widens, Tightens 2014 Revenue Outlook
10/28/2014 11:09:00 PM - RTT News


Vertex Pharmaceuticals Incorporated Plays the Earnings Waiting Game
10/28/2014 7:48:31 PM - Motley Fool


Vertex Pharma Loss Widens; Tightens FY Guidance - Quick Facts
10/28/2014 5:03:00 PM - RTT News


Vertex Pharmaceuticals Q3 14 Earnings Conference Call At 5:00 PM ET
10/28/2014 3:00:00 PM - RTT News


After-Hours Earnings Report for October 28, 2014 : FB, GILD, ESRX, MCK, APC, AFL, VRTX, EQR, AMP, WDC, MAR, EIX
10/28/2014 2:00:02 PM - NASDAQ.com News


Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog
10/27/2014 5:40:00 PM - Zacks.com


Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog
10/27/2014 1:32:00 PM - Zacks.com


Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape
10/27/2014 9:00:00 AM - Zacks.com


The 5 Most Expensive Drugs in the World
10/26/2014 12:21:02 PM - Motley Fool


Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
10/24/2014 5:20:00 PM - Zacks.com


Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog
10/24/2014 5:00:00 PM - Zacks.com


Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog
10/24/2014 4:45:00 PM - Zacks.com


Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog
10/24/2014 4:11:00 PM - Zacks.com


Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog
10/24/2014 3:39:00 PM - Zacks.com


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 5:54:00 PM - Zacks.com


Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog
10/22/2014 5:00:00 PM - Zacks.com


Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/22/2014 4:30:00 PM - Zacks.com


Regulus Therapeutics Inc. (RGLS) Has Vaulted To A New High On Study Results
10/22/2014 9:36:00 AM - RTT News


Stock Picking Grades For Health Care Sector Fund Managers
10/22/2014 9:30:00 AM - Seeking Alpha


Is Johnson & Johnson's Worst Nightmare Becoming Reality?
10/22/2014 8:39:02 AM - Motley Fool


TKMR Stays Focused On Ebola, GEVA Sets Work Rolling, FDA Panel Nod For VRTX
10/22/2014 12:24:00 AM - RTT News


Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog
10/21/2014 5:50:00 PM - Zacks.com